Reprogramming gut cells to treat short bowel syndrome

Knocking out a single gene reprograms part of the large intestine to function like the nutrient-absorbing small intestine; Weill Cornell investigators showed that this reversed the malnutrition that results when most of the small intestine is removed.

Quantum statistical approach quiets big, noisy data

A team with Cornell statisticians has develop a way to handle and simplify large data sets more efficiently than traditional methods, for when big data gets too big.

Around Cornell

Hitting the target: Imaging reveals psilocybin’s neural odyssey

Cornell researchers have identified a pair of key neurological mechanisms in the brain – a cell type and receptor – that enable the psychedelic compound’s long-lasting effects.

Omega-6 fatty acid promotes growth of aggressive type of breast cancer

Linoleic acid enhances the growth of the hard-to-treat “triple negative” breast cancer subtype.

Biblical scholar: Parables in Luke parallel Genesis stories

In his new book, Calum MacNeill Carmichael draws detailed parallels between the 14 parables unique to Luke’s gospel and Genesis stories about figures such as Jacob and Esau.

Dog owners help advance research one DNA test at a time

Thanks to a research partnership between Embark Veterinary and the College of Veterinary Medicine, DNA tests also provide findings that could improve dogs’ health.

Southern Ocean warming leads to wetter East Asia, Western US

The Southern Ocean – between Antarctica and other continents – will eventually release heat absorbed from the atmosphere, leading to projected long-term increases in precipitation over East Asia and the Western U.S.

Pregnancy may reduce long COVID risk

Pregnancy may offer some protection from developing long COVID, found a new study led by Weill Cornell Medicine, University of Rochester Medical Center, University of Utah Health and Louisiana Public Health Institute.

AI meets oncology: New model personalizes bladder cancer treatment

Researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.